Free shipping on all orders over $ 500

BMH-21

Cat. No. M3892

All AbMole products are for research use only, cannot be used for human consumption.

BMH-21 Structure
Size Price Availability Quantity
1mg USD 25 In stock
5mg USD 45 In stock
10mg USD 70 In stock
25mg USD 110 In stock
50mg USD 185 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BMH-21 is a first-in-class DNA intercalator that binds to high-frequency GC-rich sequences in ribosomal DNA genes and can effectively and rapidly inhibit the transcription of RNA polymerase I (Pol I), leading to degradation of the Pol I catalytic subunit RPA194 and non-phosphorylation of histone H2AX. H2AX is not phosphorylated.BMH-21 has broad and potent antitumor activity in NCI60 cancer cell line and inhibits tumor growth in vivo.

Customer Product Validations & Biological Datas
Source Oncol Rep (2017). Figure 2. BMH-21
Method Apoptosis assay
Cell Lines SKOV3 cells
Concentrations 1, 2 and 4 μM
Incubation Time 24 h
Results The results showed that the levels of BAX and cleaved caspase-3 increased in BMH-21 treated cells, compared with the control group
Protocol (for reference only)
Cell Experiment
Cell lines U2OS osteosarcoma cells
Preparation method Maintaining the cells at 37 °C in a humidified atmosphere containing 5% CO2. Culturing U2OS osteosarcoma cells in DMEM supplemented with 15% fetal bovine serum. Plating cells in 96-well plates at a density of 10000 cells/well in triplicate and incubated for 48 h with the compounds. Using WST-1 cell proliferation reagent to determine viability .
Concentrations ~5 μM
Incubation time 48 hours
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 360.41
Formula C21H20N4O2
CAS Number 896705-16-1
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Peltonen K, et al. Mol Cancer Ther. Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress.

[2] Colis L, et al. Oncotarget. DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response.

[3] Peltonen K, et al. Cancer Cell. A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Related DNA/RNA Synthesis Products
Clofarabine

Clofarabine inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase.

Gemcitabine Hydrochloride

Gemcitabine (Gemzar, LY188011) inhibits DNA synthesis with an IC50 of 0.06 µM.

Nelarabine

Nelarabine is a novel purine antimetabolite antineoplastic agent.

Mizoribine

Mizoribine (Bredinin) is an imidazole nucleoside and an immunosuppressive agent with an IC50 of approximately 100 μM. Mizoribine inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively.

Capecitabine

Capecitabine is an orally-administered chemotherapeutic agent. Capecitabine is a precursor, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Capecitabine may inhibit cytochrome CYP2C9 enzyme, and therefore increase levels of substrates such as phenytoin and other substrates of CYP2C9.

  Catalog
Abmole Inhibitor Catalog




Keywords: BMH-21 supplier, DNA/RNA Synthesis, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.